Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
about
Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance.Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma.Advances in redox-responsive drug delivery systems of tumor microenvironmentTumor microenvironment-responsive nanoparticles for cancer theragnostic applicationsQuercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy
P2860
Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Doxorubicin-loaded redox-respo ...... n for resistant breast cancer.
@en
type
label
Doxorubicin-loaded redox-respo ...... n for resistant breast cancer.
@en
prefLabel
Doxorubicin-loaded redox-respo ...... n for resistant breast cancer.
@en
P2093
P2860
P356
P1476
Doxorubicin-loaded redox-respo ...... in for resistant breast cancer
@en
P2093
Aiping Deng
Peiwu Geng
Shuanghu Wang
Xuhua Ying
Yifan Wang
Zhihong Yu
P2860
P304
P356
10.2147/IJN.S141229
P407
P50
P577
2017-08-22T00:00:00Z